Authors: ANDREJAK M GERSBERG M SGRO C DECOCQ G HAMEL JD MORIN M GRAS V

Citation: M. Andrejak et al., FRENCH PHARMACOVIGILANCE SURVEY EVALUATING THE HEPATIC TOXICITY OF COUMARIN, Pharmacoepidemiology and drug safety, 7, 1998, pp. 45-50

Authors: AURICHE M BERTRAND P BLAY N DANAN G HAMEL JD IMBS JL LAGIER G MICALEFF A MOORE N OLLAGNIER M REVEILLEAURICHARD S SOUBRIE C WEBER F

Citation: M. Auriche et al., GOOD PHARMACOVIGILANCE PRACTICES AND PUBL ICATIONS OF CASE-REPORTS - DISCUSSIONS AND COMMENTS, Therapie, 52(2), 1997, pp. 123-127

Authors: JOUGLARD J HAMEL JD JUVIN P

Citation: J. Jouglard et al., A PHARMACOEPIDEMIOLOGIC STUDY OF TRANDOLAPRIL, Current therapeutic research, 58(9), 1997, pp. 555-563

Authors: BOUCHER M CHASSAING C HAMEL JD POIRIER JM

Citation: M. Boucher et al., CARDIAC ELECTROPHYSIOLOGICAL EFFECTS OF PROPAFENONE AND ITS 5-HYDROXYLATED METABOLITE IN THE CONSCIOUS DOG, European journal of pharmacology, 315(2), 1996, pp. 171-177

Authors: BRILLET G STEPHAN D IMBS JL ANDREJAK A BAUMELOU A BRIAND Y BRILLET G CARON J CHAUMETRIFFAUD M DERAY G DUBRAY C ESPIE J FRIEDLANDER G GROSSE R HAMEL JD IMBS JL KREFTJAIS C LAGIER G LAVILLE M MERLE L MORIN JP ROSSI A ROTHSCHILD E STEPHAN D TOUTAIN H WINICKI MJ

Citation: G. Brillet et al., MECHANISMS, PREDICTION AND PREVENTION OF DRUGS NEPHROTOXICITY, Therapie, 48(4), 1993, pp. 321-326